We are live on ! Find out more
ZBH icon

Zimmer Biomet
ZBH

Fund managers haven’t disclosed any holdings of ZBH yet.

ZBH Hedge Fund Activity: Q1 2026 in Review

912 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q1 2026, worth a combined $17.4B — down 2.8% from $17.9B a quarter earlier.

Sellers outnumbered buyers: 107 funds closed out of ZBH and 95 opened new positions — a net loss of 12 holders — while 302 trimmed existing stakes and 312 added.

The largest buyer was Capital International Investors, adding an estimated $183M. The largest seller was T. Rowe Price Associates, cutting an estimated $517M.

  • 912 institutional investors held Zimmer Biomet (ZBH) as of Q1 2026, down from 945 in Q4 2025.
  • Funds reported $17.4B of Zimmer Biomet stock for Q1 2026, down 2.8% quarter-over-quarter.
  • 95 funds opened new Zimmer Biomet positions in Q1 2026 and 107 closed out, a net change of -12 holders.
  • The largest Zimmer Biomet buyer in Q1 2026 was Capital International Investors, an estimated $183M added.
  • The largest Zimmer Biomet seller in Q1 2026 was T. Rowe Price Associates, an estimated $517M sold.

Based on aggregated 13F filings for Q1 2026.